Literature DB >> 12843064

Pathogenic and antigenic properties of phylogenetically distinct reassortant H3N2 swine influenza viruses cocirculating in the United States.

Jürgen A Richt1, Kelly M Lager, Bruce H Janke, Roger D Woods, Robert G Webster, Richard J Webby.   

Abstract

Swine influenza is an acute respiratory disease caused by type A influenza viruses. Before 1998, swine influenza virus isolates in the United States were mainly of the classical H1N1 lineage. Since then, phylogenetically distinct reassortant H3N2 viruses have been identified as respiratory pathogens in pigs on U.S. farms. The H3N2 viruses presently circulating in the U.S. swine population are triple reassortants containing avian-like (PA and PB2), swine-like (M, NP, and NS), and human-like (HA, NA, and PB1) gene segments. Recent sequence data show that the triple reassortants have acquired at least three distinct H3 molecules from human influenza viruses and thus form three distinct phylogenetic clusters (I to III). In this study we analyzed the antigenic and pathogenic properties of viruses belonging to each of these clusters. Hemagglutination inhibition and neutralization assays that used hyperimmune sera obtained from caesarian-derived, colostrum-deprived pigs revealed that H3N2 cluster I and cluster III viruses share common epitopes, whereas a cluster II virus showed only limited cross-reactivity. H3N2 viruses from each of the three clusters were able to induce clinical signs of disease and associated lesions upon intratracheal inoculation into seronegative pigs. There were, however, differences in the severity of lesions between individual strains even within one antigenic cluster. A correlation between the severity of disease and pig age was observed. These data highlight the increased diversity of swine influenza viruses in the United States and would indicate that surveillance should be intensified to determine the most suitable vaccine components.

Entities:  

Mesh:

Year:  2003        PMID: 12843064      PMCID: PMC165376          DOI: 10.1128/JCM.41.7.3198-3205.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  H4N6 influenza virus isolated from pigs in Ontario.

Authors:  A I Karasin; C W Olsen; I H Brown; S Carman; M Stalker; G Josephson
Journal:  Can Vet J       Date:  2000-12       Impact factor: 1.008

2.  Genetic characterization of H1N2 influenza A viruses isolated from pigs throughout the United States.

Authors:  Alexander I Karasin; John Landgraf; Sabrina Swenson; Gene Erickson; Sagar Goyal; Mary Woodruff; Gail Scherba; Gary Anderson; Christopher W Olsen
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Analysis of the quality of protection induced by a porcine influenza A vaccine to challenge with an H3N2 virus.

Authors:  P P Heinen; A P van Nieuwstadt; E A de Boer-Luijtze; A T Bianchi
Journal:  Vet Immunol Immunopathol       Date:  2001-09-28       Impact factor: 2.046

4.  Emergence of H3N2 reassortant influenza A viruses in North American pigs.

Authors:  N N Zhou; D A Senne; J S Landgraf; S L Swenson; G Erickson; K Rossow; L Liu; K J Yoon; S Krauss; R G Webster
Journal:  Vet Microbiol       Date:  2000-05-22       Impact factor: 3.293

5.  Evolution of swine H3N2 influenza viruses in the United States.

Authors:  R J Webby; S L Swenson; S L Krauss; P J Gerrish; S M Goyal; R G Webster
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

6.  Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection.

Authors:  K Van Reeth; G Labarque; S De Clercq; M Pensaert
Journal:  Vaccine       Date:  2001-08-14       Impact factor: 3.641

Review 7.  Emergence of influenza A viruses.

Authors:  R J Webby; R G Webster
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

Review 8.  Integrating historical, clinical and molecular genetic data in order to explain the origin and virulence of the 1918 Spanish influenza virus.

Authors:  J K Taubenberger; A H Reid; T A Janczewski; T G Fanning
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

9.  Continued circulation of reassortant H1N2 influenza viruses in pigs in Japan.

Authors:  T Ito; Y Kawaoka; A Vines; H Ishikawa; T Asai; H Kida
Journal:  Arch Virol       Date:  1998       Impact factor: 2.574

10.  Virologic and serologic surveillance for human, swine and avian influenza virus infections among pigs in the north-central United States.

Authors:  C W Olsen; S Carey; L Hinshaw; A I Karasin
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

View more
  76 in total

1.  Pathogenicity of swine influenza viruses possessing an avian or swine-origin PB2 polymerase gene evaluated in mouse and pig models.

Authors:  Wenjun Ma; Kelly M Lager; Xi Li; Bruce H Janke; Derek A Mosier; Laura E Painter; Eva S Ulery; Jingqun Ma; Porntippa Lekcharoensuk; Richard J Webby; Jürgen A Richt
Journal:  Virology       Date:  2010-11-11       Impact factor: 3.616

2.  Aerosol Transmission from Infected Swine to Ferrets of an H3N2 Virus Collected from an Agricultural Fair and Associated with Human Variant Infections.

Authors:  Bryan S Kaplan; J Brian Kimble; Jennifer Chang; Tavis K Anderson; Phillip C Gauger; Alicia Janas-Martindale; Mary Lea Killian; Andrew S Bowman; Amy L Vincent
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

3.  Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine.

Authors:  Jürgen A Richt; Porntippa Lekcharoensuk; Kelly M Lager; Amy L Vincent; Christina M Loiacono; Bruce H Janke; Wai-Hong Wu; Kyoung-Jin Yoon; Richard J Webby; Alicia Solórzano; Adolfo García-Sastre
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

4.  Influenza A virus PB1-F2 protein contributes to viral pathogenesis in mice.

Authors:  Dmitriy Zamarin; Mila B Ortigoza; Peter Palese
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Pathogenicity and transmissibility of reassortant H9 influenza viruses with genes from pandemic H1N1 virus.

Authors:  Chuanling Qiao; Qinfang Liu; Bhupinder Bawa; Huigang Shen; Wenbao Qi; Ying Chen; Chris Ka Pun Mok; Adolfo García-Sastre; Jürgen A Richt; Wenjun Ma
Journal:  J Gen Virol       Date:  2012-08-08       Impact factor: 3.891

6.  Feral Swine in the United States Have Been Exposed to both Avian and Swine Influenza A Viruses.

Authors:  Brigitte E Martin; Hailiang Sun; Margaret Carrel; Fred L Cunningham; John A Baroch; Katie C Hanson-Dorr; Sean G Young; Brandon Schmit; Jacqueline M Nolting; Kyoung-Jin Yoon; Mark W Lutman; Kerri Pedersen; Kelly Lager; Andrew S Bowman; Richard D Slemons; David R Smith; Thomas DeLiberto; Xiu-Feng Wan
Journal:  Appl Environ Microbiol       Date:  2017-09-15       Impact factor: 4.792

7.  In vitro and in vivo replication of influenza A H1N1 WSN33 viruses with different M1 proteins.

Authors:  Zhiguang Ran; Ying Chen; Huigang Shen; Xiaoxiao Xiang; Qinfang Liu; Bhupinder Bawa; Wenbao Qi; Laihua Zhu; Alan Young; Juergen Richt; Wenjun Ma; Feng Li
Journal:  J Gen Virol       Date:  2012-12-19       Impact factor: 3.891

8.  Analysis of recombinant H7N9 wild-type and mutant viruses in pigs shows that the Q226L mutation in HA is important for transmission.

Authors:  Qinfang Liu; Bin Zhou; Wenjun Ma; Bhupinder Bawa; Jingjiao Ma; Wei Wang; Yuekun Lang; Young Lyoo; Rebecca A Halpin; Xudong Lin; Timothy B Stockwell; Richard Webby; David E Wentworth; Juergen A Richt
Journal:  J Virol       Date:  2014-05-07       Impact factor: 5.103

9.  Pathogenesis of swine influenza virus (Thai isolates) in weanling pigs: an experimental trial.

Authors:  Donruethai Sreta; Roongtham Kedkovid; Sophon Tuamsang; Pravina Kitikoon; Roongroje Thanawongnuwech
Journal:  Virol J       Date:  2009-03-25       Impact factor: 4.099

10.  From where did the 2009 'swine-origin' influenza A virus (H1N1) emerge?

Authors:  Adrian J Gibbs; John S Armstrong; Jean C Downie
Journal:  Virol J       Date:  2009-11-24       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.